Boehringer Ingelheim
Shola Adewale is an accomplished leader in clinical development and medical affairs, currently serving as the Director of Clinical Development Strategy Lead at Boehringer Ingelheim since October 2020. With extensive experience in the pharmaceutical and biotechnology industries, Shola has held prominent roles such as Executive Director of Global Medical Affairs at Amicus Therapeutics, Senior Director of Medical Affairs at Salix Pharmaceuticals, and Medical Director at Eisai. Expertise encompasses diverse therapeutic areas including gene therapy, pain management, and gastrointestinal disorders. Shola holds a PhD in Pharmacological and Physiological Science from Saint Louis University and an MBA from Saint Joseph's University.
This person is not in any teams
This person is not in any offices
Boehringer Ingelheim
116 followers
At Boehringer Ingelheim they create value through innovation with one clear goal: to improve the lives of patients. They develop breakthrough therapies and innovative healthcare solutions in areas of unmet medical need for both humans and animals. As a family owned company, they focus on long-term performance. They are powered by 50.000 employees globally who nurture a diverse, collaborative and inclusive culture. Learning and development for all employees is key, because your growth is their growth.